Tenet Healthcare (THC) Tops Q1 EPS by 27c; raises guidance

Tenet Healthcare (NYSE: THC) reported Q1 EPS of $1.42, $0.27 better than the analyst estimate of $1.15. Revenue for the quarter came in at $5.02 billion versus the consensus estimate of $4.85 billion.

GUIDANCE:

Tenet Healthcare sees Q2 2023 EPS of $1.07-$1.30. Tenet Healthcare sees Q2 2023 revenue of $4.8-5.0 billion.

Tenet Healthcare sees FY2023 EPS of $4.92-$6.09. Tenet Healthcare sees FY2023 revenue of $19.8-20.2 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Goldman Sachs sees US stocks dip on tech earnings and macro shifts
• Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance